McKesson Corporation

McKesson Corporation is an American publicly traded company that operates as a global healthcare services leader, distributing pharmaceuticals and providing health information technology, medical supplies, and health management tools. The company's mission is "to advance health outcomes for all by connecting and equipping healthcare providers with the medicines, technologies and services they need." Headquartered in Irving, Texas, McKesson plays a critical role in the global healthcare supply chain.

McKesson's core business segments include pharmaceutical distribution, where it delivers approximately one-third of all pharmaceutical products used in North America, and medical-surgical supply distribution, offering over 300,000 products. The company also provides advanced health information technology solutions, specialty pharmacy services, and oncology and biopharma services. Its diverse customer base spans retail pharmacies, hospitals, health systems, long-term care facilities, specialty clinics, and government agencies.

As the nation's largest healthcare company and the ninth-largest company by revenue in the United States, McKesson is strategically focusing on high-growth areas such as oncology, multispecialty care, and biopharma services. Brian S. Tyler serves as the Chief Executive Officer. In recent news, the company declared a quarterly dividend of $0.82 per share in April 2026 and signed an agreement with Apollo Funds for a strategic minority interest in its Medical-Surgical Solutions segment in March 2026, with plans to separate this unit into an independent company. McKesson also completed its exit from European operations in January 2026 to further prioritize growth in its core strategic areas.